FREE NEWSLETTER

Where the Money Is Actually Going: Capital Allocation in Global Spirits in 2026

Strategy presentations tell you what a company wants to be. Capital allocation decisions tell you what it actually believes.

The distinction matters most during a downturn. When revenue is under pressure, every allocation decision reveals a genuine conviction – because the opportunity cost of getting it wrong is higher, the financial discipline required is more visible, and the difference between companies that manage through a correction and ones that are managed by it becomes legible in the numbers.

Six major spirits companies have reported results in the first quarter of 2026. Reading their financial statements not as six separate stories but as one collective data set reveals a specific pattern. The companies that are positioning themselves best for the next cycle share a set of capital allocation characteristics. The companies that are not share a different set. The pattern is more instructive than any of the individual results alone.

The methodology

Capital allocation, for the purposes of this analysis, means four things: where marketing investment is going and where it is being cut; how capex is being managed relative to revenue pressure; what is happening to leverage and cash generation; and what the disposal and acquisition decisions reveal about portfolio conviction.

Reported organic growth rates matter but they are the output. The allocation decisions are the input. A company can report flat organic growth while simultaneously concentrating resources into its highest-return markets and divesting its lowest-return assets – that is a fundamentally different position from a company reporting flat organic growth while cutting investment equally across the portfolio to protect short-term margin. The numbers look the same on the surface. The underlying trajectories are entirely different.

Diageo: concentrating resources, but the direction is still being set

Free newsletter
Daily drinks industry intelligence. No subscription needed.
Continue reading
Start your 30-day trial for £1 / $1 / €1. Cancel anytime.
  • -Daily coverage
  • -Market and category analysis
  • -Financial results coverage
  • -Practical industry guides
  • -Interviews
  • -Monthly intelligence briefing
Start 30-day trial - £1 / $1 / €1
Already a member? Sign in here.